Vinita Gupta

May 26-27, 2021 | Virtual Conference

Register Today

Vinita Gupta

CEO, Lupin

Vinita Gupta is the CEO of Lupin Limited (Lupin) and Chairperson of Lupin Inc., (LI) and its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI).

Vinita is a graduate in pharmacy from the University of Mumbai and earned an MBA degree from the Kellogg School of Management at Northwestern University. Vinita has been instrumental in formulating and executing the strategy that has grown the company into a global pharmaceutical powerhouse, amongst the most exciting growth stories in the pharmaceutical industry. Through a combination of organic growth and strategic acquisitions, she has led the company’s global expansion plans. In particular, she founded, led and established Lupin’s largest region, the United States.

Vinita has been regularly named by Forbes Asia in its Top 50 Power Business Women listings for the Asia Pacific region. Vinita has been widely recognized for her leadership and vision, including the BusinessToday Hall of Fame – Most Powerful Women in Business, Outstanding Business Woman Leader of the Year by CNBC India Business Leader Awards, Forbes India Leadership Awards 2016 Entrepreneur of the Year, Ernst & Young (EY) Entrepreneur of the Year 2015 as well as the inaugural EY, U.S. 2012 Family Business Award of Excellence and EY Entrepreneur of the Year® 2012 award winner for Health Services and Technology in Maryland. She is regarded as amongst the most influential Indian Business Women globally.

In 2017 Vinita was appointed to the Board of Directors for Intrexon Corporation, now known as Precigen Corporation. In the same year, she also became a member of the Global Advisory Board at the Kellogg School of Management at Northwestern University.

Vinita currently resides with her husband and son in Naples, Florida, where Lupin Inc.’s global executive offices are also based.

Get Started
& Register

Dividing Lines

Whether you are an AAM member, general attendee, or exhibitor, come meet the leaders and decision-makers who are determining the future of generics and biosimilars.

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Access 2021 will use the information you provide on this form to be in touch with you and to provide updates and marketing.

Get Started
& Register

Dividing Lines

Whether you are an AAM member, general attendee, or exhibitor, come meet the leaders and decision-makers who are determining the future of generics and biosimilars.

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Access 2021 will use the information you provide on this form to be in touch with you and to provide updates and marketing.
Skip to content